RIPK1-IN-18

• UNSPSC Description:

  RIPK1-IN-18 (compound i) is a potent inhibitor of RIPK1. RIPK1-IN-18 can be used in autoimmune diseases research[1].

• Target Antigen:

  RIP kinase

• Type:

  Reference compound

• Related Pathways:

  Apoptosis

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ripk1-in-18.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1C2=C(CCN1CC3=CC(OC(F)(F)F)=CC=C3F)N=CC(C4=CC5=NC(N)=NN5C=C4)=C2

• Molecular Weight:

  472.40

• References & Citations:

  [1]Zhou FuSHeng, et al. Crystal form of ripk1 inhibitor, acid salt thereof, and crystal form of acid salt thereof. China TW202306954A. 2023-02-16.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2682889-01-4